MGTX
MeiraGTx Holdings PLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$888.13M
P/E Ratio
—
EPS
$-1.48
Beta
1.26
52W High
$11.85
52W Low
$6.07
50-Day MA
$9.62
200-Day MA
$8.35
Dividend Yield
—
Profit Margin
-151.10%
Forward P/E
1.61
PEG Ratio
—
About MeiraGTx Holdings PLC
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focused on developing treatments for patients living with serious illnesses. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $79.76M |
| Gross Profit (TTM) | $76.09M |
| EBITDA | $-92.72M |
| Operating Margin | -13931.00% |
| Return on Equity | -368.20% |
| Return on Assets | -28.10% |
| Revenue/Share (TTM) | $0.98 |
| Book Value | $-0.71 |
| Price-to-Book | 228.30 |
| Price-to-Sales (TTM) | 11.14 |
| EV/Revenue | 11.32 |
| EV/EBITDA | -3.29 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -84.80% |
| Shares Outstanding | $92.61M |
| Float | $52.26M |
| % Insiders | 17.80% |
| % Institutions | 60.57% |
Historical Volatility
HV 10-Day
67.79%
HV 20-Day
64.20%
HV 30-Day
54.30%
HV 60-Day
73.54%
HV Rank
55.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($28.25 target)
2
Strong Buy6
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026